| MR编号 | NL/H/3002/001 |
|---|
| 药品名称 | Biphozyl 22 mmol/l |
|---|
| 活性成分 | - magnesium chloride hexahydrate 3.05 g/l
- Potassium chloride 0.31 g/l
- Sodium chloride 7.01 g/l
- Sodium carbonate 2.12 g/l
- SODIUM PHOSPHATE DIBASIC dihydrate 0.19 g/l
|
|---|
| 剂型 | Solution for haemodialysis/haemofiltration |
|---|
| 上市许可持有人 | Baxter Holding B.V.,
Kobaltweg 49,
3542CE Utrecht,
The Netherlands |
|---|
| 参考成员国 - 产品名称 | Netherlands (NL) Biphozyl 22 mmol/l, oplossing voor hemofiltratie en hemodialys |
|---|
| 互认成员国 - 产品名称 | - Germany (DE)
- Denmark (DK)
- Belgium (BE)
- Luxembourg (LU)
- Iceland (IS)
- Ireland (IE)
- Austria (AT)
- France (FR)
- Spain (ES)
- Portugal (PT)
- Italy (IT)
- Greece (GR)
- Sweden (SE)
- Norway (NO)
- Finland (FI)
- Poland (PL)
- Latvia (LV)
- Lithuania (LT)
- Estonia (EE)
- Hungary (HU)
- Bulgaria (BG)
- Cyprus (CY)
- Czechia (CZ)
- Romania (RO)
- Slovakia (SK)
- Slovenia (SI)
- Malta (MT)
- Croatia (HR)
- United Kingdom (Northern Ireland) (XI)
|
|---|
| 许可日期 | 2014/10/20 |
|---|
| 最近更新日期 | 2025/08/19 |
|---|
| 药物ATC编码 | | 申请类型 | - TypeLevel1：Known Active Substance
- TypeLevel2：Initial Application
- TypeLevel3：Bibliographic Art 10 a Dir 2001/83/EC
- TypeLevel4：Chemical Substance
- TypeLevel5：Prescription Only
|
|---|
| 附件文件下载 | |
|---|
| 市场状态 | Positive |
|---|
|
|---|